L. Mary Smith - Oct 13, 2021 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Chief Development Officer
Signature
/s/ Francis I. Perier, Jr as Attorney-in-Fact
Stock symbol
SWTX
Transactions as of
Oct 13, 2021
Transactions value $
-$536,675
Form type
4
Date filed
10/13/2021, 08:24 PM
Previous filing
Jul 14, 2021
Next filing
Jan 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Options Exercise $23K +10K +5.97% $2.30* 178K Oct 13, 2021 Direct F1
transaction SWTX Common Stock Sale -$560K -10K -5.63% $55.97 168K Oct 13, 2021 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWTX Stock Option (Right to Buy) Options Exercise $0 -10K -10.6% $0.00 84.3K Oct 13, 2021 Common Stock 10K $2.30 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option exercises and sale transactions reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.95 to $56.99, inclusive.
F3 Includes 27,304 restricted stock awards which are subject to forfeiture until they vest.
F4 This option began to vest and become exercisable in 48 equal monthly installments beginning on April 22, 2019.